A study published in Nature Biotechnology reveals a powerful new use for artificial intelligence: designing small, drug-like ...

Proxofim peptide—also known as FOXO4‑DRI (D‑Retro‑Inverso)—emerges as a novel investigative tool in cellular and molecular ...

Detailed price information for Amphastar Pharma (AMPH-Q) from The Globe and Mail including charting and trades.

Boosting peptide design Finding the holy grail of re-engineering peptide design -- for better antibiotics and beyond Date: May 10, 2021 Source: Monash University Summary: Peptides play a vital ...

In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically "undruggable" protein, in just two months ...

AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced compelling in vitro results demonstrating that its artificial ...

Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology ...

Cell-penetrating peptides are a class of short peptides with a length of 5~30 amino acids, which can carry peptides, nucleic acids, small molecules of drugs, and virus particles through cell membranes ...